Pharma air corridor links Middle East and Europe

Plans are in place to develop a pharma air corridor between Abu Dhabi and Belgium.

The fully compliant, origin-to-destination global distribution pharma air corridor between Abu Dhabi and Brussels airports is anticipated to serve the world in vaccine delivery and future life science needs.

Led by the Department of Health – Abu Dhabi, a declaration of collaboration has been signed between the HOPE Consortium, Abu Dhabi Airports Company (ADAC), Brussels Airport Company and Pharma.Aero to carry out the initiative.

The development of the dedicated pharma air corridor will leverage API-IoT devices-webforms-internet shared with relevant stakeholders to monitor pharma shipments closely.

This trade lane will unite key compliant and sector certified supply chain stakeholders, including forwarders and ground handling agents.

The collaboration builds on the capabilities of Abu Dhabi’s healthcare sector as a leading life sciences hub and the efforts of the HOPE Consortium in providing vaccine solutions for the world.

Mohamed Juma Al Shamisi, chairman of the HOPE Consortium executive committee and group chief executive of AD Ports Group, said: “The HOPE Consortium is pleased to collaborate in the development of a fully compliant origin-to-destination pharma air corridor between Abu Dhabi and Belgium.”

A second declaration of collaboration has been signed by the HOPE Consortium, Pharma.Aero, Khalifa University of Science and Technology and the University of Antwerp to host the second edition of the ‘Pharma Logistics Masterclass’, a course focused on critical challenges and developments in pharma supply chains and logistics, by Khalifa University in Abu Dhabi from September 5-9, 2022.

Major upgrade for Etihad Cargo’s Abu Dhabi hub

Brussels Airport launches Stargate project for greener aviation